CLOSED - Clinical Trial on Moderate to Severe Atopic Dermatitis Varies
Description
A local research facility is seeking participants for a clinical research study on moderate-to-severe atopic dermatitis. The purpose of this clinical study is to assess the immune response to 2 different approved vaccines after receiving an investigational injectable medication for atopic dermatitis.
Qualified candidates receive no-cost medication, study-related care and are eligible for financial compensation.
Space is limited, subject to availability. Criteria for qualification are subject to change at any time and without notice.
Other focus groups:

Focus Groups
Media & Entertainment
Focus Group on Gaming
View Details

Focus Groups
Technology
Focus Group on Social Media
View Details

Focus Groups
Technology
Focus Group on Telecomm Services
View Details

Focus Groups
Health & Beauty
Focus Group on Hypertension
View Details

Focus Groups
Media & Entertainment
Focus Group on Gaming
View Details

Focus Groups
Health & Beauty
Focus Group on Heart Health
View Details

Focus Groups
Household & Lifestyle
Focus Group on Travel
View Details

Focus Groups
Household & Lifestyle
Focus Group on Dating
View Details

Focus Groups
Sociopolitics
Focus Group on Legal Opinions
View Details